Source: 4-traders

University of Freiburg: RELIEF THERAPEUTICS : announces an agreement with the University of Freiburg for the clinical development of Aviptadil in Sarcoidosis

(4-traders.com) RELIEF THERAPEUTICS Holding SA announces an agreement with the University of Freiburg for the clinical development of Aviptadil in Sarcoidosis that led to a grant by the Deutsche Forschungsgemeinschaft Geneva, Switzerland, 6 Novembre 2017 RELIEF THERAPEUTICS Holding SA announces that the...http://www.4-traders.com/RELIEF-THERAPEUTICS-HOLDI-5527488/news/RELIEF-THERAPEUTICS-announces-an-agreement-with-the-University-of-Freiburg-for-the-clinical-develo-25445206/?utm_medium=RSS&utm_content=20171106

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
5.0-10K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100